News about Manufacturing

Fujifilm Cellular Dynamics Opens New iPSC Manufacturing Facility in Madison

Fujifilm Cellular Dynamics opens a new iPSC manufacturing facility and headquarters in Madison as part of Fujifilm’s USD 200 million investment to expand cell therapy and stem cell manufacturing capabilities in the US.

Manufacturing | 21/05/2026 | By News Bureau |  132

Amgen Adds USD 300 Million to US Manufacturing, Total Nears USD 2 Billion

Amgen invests an additional USD 300 Million in US manufacturing, bringing total investment to nearly USD 2 Billion to strengthen supply chain resilience, and next-generation technology.

Manufacturing | 06/05/2026 | By News Bureau |  152

Novartis Expands US Manufacturing and R&D with Seventh Facility

Novartis advances its US expansion plan with a seventh facility, including a new API site in North Carolina to enable end-to-end manufacturing and accelerate delivery of innovative medicines.

Manufacturing | 04/05/2026 | By News Bureau |  139

WHO Scales Biomanufacturing Workforce Network to Advance Equitable Access

The World Health Organization (WHO) has expanded its global biomanufacturing workforce network under the 2023 training initiative, following a rigorous selection process to strengthen equitable access to medicines and global health security.

Manufacturing | 02/05/2026 | By News Bureau |  107

OrganaBio LLC, RxMP Therapeutics Partner for cGMP Manufacturing of Novel Bleeding Control Therapy

OrganaBio LLC partners with RxMP Therapeutics to manufacture RMP-402, a next-generation therapy designed to rapidly stop severe bleeding in both civilian and military settings.

Manufacturing | 27/04/2026 | By News Bureau |  141

China Approves GSK's Exdensur for Chronic Rhinosinusitis with Nasal Polyps

GSK plc has received approval from China’s National Medical Products Administration (NMPA) for Exdensur (depemokimab) as an add-on therapy for adult patients with Chronic Rhinosinusitis with Nasal Polyps who remain inadequately controlled with systemic corticosteroids or surgery.

Manufacturing | 09/04/2026 | By Darshana |  122

Altruist Biologics Wins First Commercial Manufacturing License for Hangzhou Facility

Altruist Biologics secures its first GMP commercial manufacturing license for its Hangzhou facility, featuring four 20,000L bioreactors. Achieved in just two months, this milestone highlights strong technical expertise and global-quality standards.

Manufacturing | 09/04/2026 | By News Bureau |  164

Samsung Biologics Expands into US with GSK Facility Acquisition in Maryland

Samsung Biologics has completed the acquisition of a biologics manufacturing facility in Rockville, Maryland from GSK, marking its first manufacturing presence in the United States.

Manufacturing | 02/04/2026 | By Darshana |  156

Lilly to Acquire Centessa in USD 6.3 Billion Deal, Expands Neuroscience Pipeline

Eli Lilly and Company has announced a definitive agreement to acquire Centessa Pharmaceuticals plc, strengthening its neuroscience portfolio and advancing next-generation therapies for sleep-related and neurological disorders.

Manufacturing | 01/04/2026 | By Darshana |  150

Eveliqure and Serum Institute of India Partner to Develop Anti-Diarrhoeal Vaccines

Eveliqure and Serum Institute of India (SII) have partnered to develop anti-diarrhoeal vaccines, with Eveliqure set to receive an upfront payment, milestone-based earnings and royalties on net sales, while SII will lead development and global commercialisation.

Manufacturing | 23/03/2026 | By News Bureau |  144